Charles W. Stark - Nov 23, 2021 Form 3 Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Role
SVP, Clinical Development
Signature
Charles W. Stark
Stock symbol
EMMA
Transactions as of
Nov 23, 2021
Transactions value $
$0
Form type
3
Date filed
12/28/2021, 06:37 PM
Next filing
Jan 17, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EMMA Common stock, $0.001 par value 3.48K Nov 23, 2021 Direct
holding EMMA Common stock, $0.001 par value 14.7K Nov 23, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EMMA Stock Option Nov 23, 2021 Common Stock 105K $3.43 Direct
holding EMMA Stock Option Nov 23, 2021 Common Stock 105K $4.76 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares shown are owned jointly with Kimxa Stark, the reporting person's wife.